Health Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate… James Pereira May 9, 2023 <!-- Name:DistributionId Value:8834229 --> <!--… Read More...
Health Adamis Announces Review of Strategic Alternatives James Pereira Oct 4, 2022 SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a specialty… Read More...
Health Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of… James Pereira Jul 30, 2022 SAN DIEGO, July 29, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an… Read More...
Health Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster Model James Pereira Mar 22, 2022 SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that… Read More...
Health Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update James Pereira Nov 23, 2021 SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical… Read More...
Health Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update James Pereira Nov 20, 2021 SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical… Read More...
Health Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment… James Pereira Sep 2, 2021 SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the… Read More...
Health Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 James Pereira Jun 13, 2021 SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that… Read More...
Health Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ James Pereira May 29, 2021 SAN DIEGO, May 28, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical… Read More...